Vaccitech Company
Barinthus Biotherapeutic induces T cells and antibodies to treat and prevent disease.
Investors
%20.jpg)
Connections from
Founded Date:
2023
Investor Type:
N/A
Employee Number:
4
Investment Stage:
N/A
Funding Status:
N/A
Number Of Exists:
N/A
Technology:
Personalized Medicine
Industry:
Personalized Medicine
Headquarters:
Oxford, Oxfordshire, United Kingdom
Estimated Revenue:
$13.42 million